Scholarlink

Background and aim <p>Anal human papillomavirus (HPV) infection can cause benign and precancerous intra- and perianal lesions. Multiple treatments, including liquid nitrogen cryotherapy, are available with varying efficacy, safety and logistic issues. Little consensus exists considering best clinical practice. This study aims to assess efficacy, safety, and practical applicability of a handheld, noncontact cryotherapy device using nitrous oxide to treat nonmalignant HPV-related intra- and perianal lesions.</p> Methods <p>A single-center exploratory, open-label proof of concept case series was performed followed by a prospective single-arm interventional study with standardized treatment protocol, conducted at the proctology clinic of the Ghent University Hospital (Belgium). Consecutive patients presenting with benign, intra-, and/or perianal HPV-related lesions were offered noncontact cryotherapy treatment. Primary endpoint was clinical remission, within 4&#xa0;months of treatment. Secondary endpoints included 1 year recurrence rate and treatment-emergent adverse events. Practical applicability of the device was evaluated and technical properties were adjusted to maximize applicability in everyday ambulatory proctology practice.</p> Results <p>In total, 73 patients were treated. Clinical remission within 4&#xa0;months was seen in 47/63 (74.6%). No major adverse events were noted and treatment was well tolerated. Compliance to the study protocol follow-up schedule was rather low in this patient population.</p> Conclusions <p>This study is the first to describe this noncontact nitrous oxide cryotherapy device for treatment of intra- and perianal nonmalignant HPV-related lesions. Efficacy rates were high and treatment was well tolerated.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

First proctological application of a noncontact nitrous oxide cryotherapy device treating nonmalignant intra- and perianal HPV-related lesions

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年5月15日

查看全文
  • H. Ruymbeke,
  • J. Geldof,
  • T. Holvoet,
  • M. Surmont,
  • D. De Looze

摘要

Background and aim

Anal human papillomavirus (HPV) infection can cause benign and precancerous intra- and perianal lesions. Multiple treatments, including liquid nitrogen cryotherapy, are available with varying efficacy, safety and logistic issues. Little consensus exists considering best clinical practice. This study aims to assess efficacy, safety, and practical applicability of a handheld, noncontact cryotherapy device using nitrous oxide to treat nonmalignant HPV-related intra- and perianal lesions.

Methods

A single-center exploratory, open-label proof of concept case series was performed followed by a prospective single-arm interventional study with standardized treatment protocol, conducted at the proctology clinic of the Ghent University Hospital (Belgium). Consecutive patients presenting with benign, intra-, and/or perianal HPV-related lesions were offered noncontact cryotherapy treatment. Primary endpoint was clinical remission, within 4 months of treatment. Secondary endpoints included 1 year recurrence rate and treatment-emergent adverse events. Practical applicability of the device was evaluated and technical properties were adjusted to maximize applicability in everyday ambulatory proctology practice.

Results

In total, 73 patients were treated. Clinical remission within 4 months was seen in 47/63 (74.6%). No major adverse events were noted and treatment was well tolerated. Compliance to the study protocol follow-up schedule was rather low in this patient population.

Conclusions

This study is the first to describe this noncontact nitrous oxide cryotherapy device for treatment of intra- and perianal nonmalignant HPV-related lesions. Efficacy rates were high and treatment was well tolerated.